tirzepatide effects on heart Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology New evidence shows tirzepatide and

The weight loss medications that we prescribe as a part of our weight loss program in Stockton, California, whether they are GLP-1 medications or non- GLP-1 medications, help people lose weight through different mechanisms, making them suitable for various needs and health profiles

If youre at all interested in it, its kind of an interesting history

It is produced by specialised cells in the small intestine known as L-cells, and plays a central role in regulating blood sugar levels, appetite, and digestion (1,2)

The earliest UK private access via online pharmacies is likely in 2027 or 2028, with NHS access following a NICE appraisal

Key Takeaways Tirzepatide (Zepbound) produces greater average weight loss than semaglutide (Wegovy) across both clinical trials and the first direct head-to-head comparison, 20.9% versus 14.9% in separate Phase 3 trials, and 20.2% versus 13.7% in the SURMOUNT-5 trial published in the New England Journal of Medicine

Optional check-ins anytime you need them